Skip to content

TCNNF

Trulieve Cannabis Corp.

Healthcare · Pharmaceuticals · US

Ask drillr

Income statement

MetricTTM2025
Revenue
Total Revenue1.1B1.2B
Cost of Revenue461.6M470.0M
Gross Profit677.4M711.2M
Operating Expenses
R&D Expense
SG&A Expense432.0M445.2M
General & Admin Expense
Selling & Marketing Expense
Other Expenses519.7M117.6M
Total Operating Expenses951.7M562.8M
Cost and Expenses1.4B1.0B
Operating Income (EBIT)(274.3M)148.3M
Non-Operating
Interest Income13.6M14.5M
Interest Expense56.8M63.5M
Net Interest Income(43.3M)(48.9M)
Other Non-Op Income/Expense(51.7M)(56.8M)
Non-Operating Income (excl Interest)(5.2M)(6.6M)
EBT (Pre-Tax Income)(325.9M)91.5M
Income Tax Expense144.8M208.1M
Bottom Line
Net Income(473.4M)(116.4M)
Earnings from Cont. Ops(470.7M)(116.6M)
Earnings from Discont. Ops(5.5M)(5.6M)
Bottom Line Net Income(475.2M)(116.4M)
Per Share
Basic EPS($2.45)($0.61)
Diluted EPS($2.45)($0.61)
Revenue Per Share$5.91$6.17
Shares
Basic Shares Outstanding192.7M191.3M
Diluted Shares Outstanding192.7M191.3M
Profitability Metrics
EBITDA(138.3M)328.3M
D&A130.8M173.4M
EBIT(269.1M)154.9M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026